RU2580622C2 - Композиция и ее применение в лечении анальных трещин - Google Patents

Композиция и ее применение в лечении анальных трещин Download PDF

Info

Publication number
RU2580622C2
RU2580622C2 RU2014129391/15A RU2014129391A RU2580622C2 RU 2580622 C2 RU2580622 C2 RU 2580622C2 RU 2014129391/15 A RU2014129391/15 A RU 2014129391/15A RU 2014129391 A RU2014129391 A RU 2014129391A RU 2580622 C2 RU2580622 C2 RU 2580622C2
Authority
RU
Russia
Prior art keywords
composition
extract
glucan
beta
hibiscus
Prior art date
Application number
RU2014129391/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2014129391A (ru
Inventor
Филиппо БАСТИЯ
Маурицио САККОМАННО
Original Assignee
ТХД С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2580622(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ТХД С.п.А. filed Critical ТХД С.п.А.
Publication of RU2014129391A publication Critical patent/RU2014129391A/ru
Application granted granted Critical
Publication of RU2580622C2 publication Critical patent/RU2580622C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5775—Hibiscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2014129391/15A 2012-01-30 2012-01-30 Композиция и ее применение в лечении анальных трещин RU2580622C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (2)

Publication Number Publication Date
RU2014129391A RU2014129391A (ru) 2016-03-27
RU2580622C2 true RU2580622C2 (ru) 2016-04-10

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014129391/15A RU2580622C2 (ru) 2012-01-30 2012-01-30 Композиция и ее применение в лечении анальных трещин

Country Status (23)

Country Link
US (1) US9345747B2 (OSRAM)
EP (1) EP2646039B1 (OSRAM)
JP (1) JP5903505B2 (OSRAM)
KR (1) KR101599447B1 (OSRAM)
CN (2) CN109865000A (OSRAM)
AU (1) AU2012368815B2 (OSRAM)
BR (1) BR112014018850A8 (OSRAM)
CA (1) CA2863369C (OSRAM)
DK (1) DK2646039T3 (OSRAM)
ES (1) ES2485490T3 (OSRAM)
HR (1) HRP20140594T1 (OSRAM)
IL (1) IL233875A (OSRAM)
IN (1) IN2014MN01733A (OSRAM)
MX (1) MX336204B (OSRAM)
PL (1) PL2646039T3 (OSRAM)
RS (1) RS53457B (OSRAM)
RU (1) RU2580622C2 (OSRAM)
SA (1) SA113340239B1 (OSRAM)
SG (1) SG11201404413UA (OSRAM)
SI (1) SI2646039T1 (OSRAM)
TW (1) TWI495476B (OSRAM)
WO (1) WO2013114410A1 (OSRAM)
ZA (1) ZA201405208B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100118A1 (en) 2013-12-24 2015-07-02 The Procter & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
EP3787654A4 (en) * 2018-05-02 2022-04-20 Montero Gida Sanayi Ve Ticaret Anonim Sirketi TOPICAL COMPOSITIONS FOR STRETCH MARKS ON THE SKIN

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046205A1 (fr) * 1997-04-16 1998-10-22 Laboratoires Serobiologiques (Societe Anonyme) Utilisation d'une fraction proteique extraite de graines d'hibiscus esculentus en cosmetique
JP2004051533A (ja) * 2002-07-19 2004-02-19 Ichimaru Pharcos Co Ltd ヒアルロン酸合成促進剤
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−１．３−１．６グルカン（アウレオバシジウム培養液）の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
PT1620469E (pt) * 2003-05-02 2013-05-07 Ceapro Inc Método melhorado de extração e purificação para cereal -glucano
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046205A1 (fr) * 1997-04-16 1998-10-22 Laboratoires Serobiologiques (Societe Anonyme) Utilisation d'une fraction proteique extraite de graines d'hibiscus esculentus en cosmetique
JP2004051533A (ja) * 2002-07-19 2004-02-19 Ichimaru Pharcos Co Ltd ヒアルロン酸合成促進剤
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BRYANT LA et all. Processing, functional, and nutritional properties of okra seed products // Journal of food science, wiley-blackwell publishing, INC, US, vol.53, no/3, 01.01.1988, p.810-816. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Also Published As

Publication number Publication date
JP2015504915A (ja) 2015-02-16
RU2014129391A (ru) 2016-03-27
ZA201405208B (en) 2015-10-28
MX2014009244A (es) 2015-03-19
IN2014MN01733A (OSRAM) 2015-07-10
BR112014018850A2 (OSRAM) 2017-06-20
CN109865000A (zh) 2019-06-11
BR112014018850A8 (pt) 2017-07-11
CN104114177A (zh) 2014-10-22
SI2646039T1 (sl) 2014-10-30
WO2013114410A1 (en) 2013-08-08
AU2012368815B2 (en) 2018-03-01
TW201334787A (zh) 2013-09-01
DK2646039T3 (da) 2014-08-11
MX336204B (es) 2016-01-11
IL233875A0 (en) 2014-09-30
SG11201404413UA (en) 2014-10-30
KR20140127296A (ko) 2014-11-03
SA113340239B1 (ar) 2015-07-07
RS53457B (sr) 2014-12-31
HK1186378A1 (en) 2014-03-14
US20140303094A1 (en) 2014-10-09
AU2012368815A1 (en) 2014-09-18
US9345747B2 (en) 2016-05-24
ES2485490T3 (es) 2014-08-13
CA2863369A1 (en) 2013-08-08
HRP20140594T1 (hr) 2014-10-24
JP5903505B2 (ja) 2016-04-13
TWI495476B (zh) 2015-08-11
CA2863369C (en) 2020-03-10
EP2646039B1 (en) 2014-05-14
IL233875A (en) 2017-01-31
EP2646039A1 (en) 2013-10-09
KR101599447B1 (ko) 2016-03-14
PL2646039T3 (pl) 2014-10-31

Similar Documents

Publication Publication Date Title
JP6121561B2 (ja) 組織再生のための組成物および方法
JP5203955B2 (ja) アミノ酸とヒアルロン酸ナトリウムを基にしたクリーム剤の形態の創傷治癒医薬組成物
AU2012368815B2 (en) A composition and use thereof in the treatment of anal rhagades
BR112021003877A2 (pt) composições farmacêuticas à base de óleo semissólidas que contêm pirfenidona para aplicação em reparo tecidual
EP2763686A1 (en) Composition for the treatment of skin lesions
US10426803B2 (en) Topical medicament for skin and mucosal injuries
US20020176876A1 (en) Topical therapeutic skin care system
TWI873233B (zh) 用於治療皮膚疾症之消炎化合物
EP3087993B1 (en) Pharmaceutical composition comprising acetyl hexapeptide-8 and pentapeptide-18 for treating anal fissures
WO2024073011A1 (en) Topical compositions and methods for the treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
JP2009513587A (ja) アミノ酸とヒアルロン酸ナトリウムを基にした滅菌粉末の形態の創傷治癒医薬組成物
EP3461490A1 (en) Pharmaceutical composition for treating hemorrhoidal disaese
JP2016033137A (ja) 裂肛の治療における組成物及びその使用
HK1186378B (en) A composition and use thereof in the treatment of anal rhagades
AU2023355027A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
KR100630240B1 (ko) 여드름에서 폐쇄된 모공을 열어주고 피지분비를 촉진하는조성물 및 이를 포함하는 화장료
CN105326741A (zh) 一种胼胝膏及其制备方法

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180131